title: Haematological cancer: Repositioned to attack CML cells.
authors.forename: David
authors.initials: D
authors.lastname: Killock
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology* / Q000627:therapeutic use*; D001549:Benzamides / Q000008:administration & dosage*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000473:pathology*; D014411:Neoplastic Stem Cells / Q000187:drug effects*; D047495:PPAR gamma / Q000819:agonists*; D010879:Piperazines / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D045162:Thiazolidinediones / Q000008:administration & dosage*
chemical_list: D001549:Benzamides; D047495:PPAR gamma; D010879:Piperazines; D011743:Pyrimidines; D045162:Thiazolidinediones